Nomura initiated coverage on
Colony Starwood Homes SFR with a Buy rating. The target price for Colony Starwood Homes is set to $29. Colony Starwood Homes shares closed at $21.52 on Friday.
Analysts at H.C. Wainwright initiated coverage on
VolitionRX Ltd VNRX with a Buy rating. The target price for VolitionRX is set to $12. VolitionRX shares closed at $3.77 on Friday.
Analysts at KeyBanc initiated coverage of
Acadia Healthcare Company IncACHC with a Overweight rating. The target price for Acadia Healthcare is set to $85. Acadia Healthcare shares closed at $61.03 on Friday.
Analysts at Credit Suisse initiated coverage on
LINDBLAD EXPEDITIONS HLDGS INCLIND with a Outperform rating. The target price for Lindblad Expeditions Holdings is set to $14. Lindblad Expeditions Holdings shares closed at $10.02 on Friday.
Canaccord Genuity initiated coverage of
Halozyme Therapeutics, Inc. HALO with a Buy rating. Halozyme Therapeutics shares closed at $8.80 on Friday.
Analysts at Nomura initiated coverage on
Altisource Residential CorpRESI with a Neutral rating. The target price for Altisource Residential is set to $11. Altisource Residential shares closed at $9.95 on Friday.
Analysts at H.C. Wainwright initiated coverage on
Eyegate Pharmaceuticals IncEYEG with a Buy rating. The target price for Eyegate Pharmaceuticals is set to $10. Eyegate Pharmaceuticals shares closed at $1.70 on Friday.
Chardan Capital initiated coverage on
Skyworks Solutions IncSWKS with a Buy rating. The target price for Skyworks Solutions is set to $100. Skyworks Solutions shares closed at $68.92 on Friday.
Canaccord Genuity initiated coverage on
Summit Therapeutics PLC (ADR) SMMT with a Buy rating. Summit Therapeutics shares closed at $8.52 on Friday.
Analysts at Northland Securities initiated coverage on
Fortinet Inc FTNT with a Outperform rating. Fortinet shares closed at $28.14 on Friday.
Loading...
Loading...
ACHCAcadia Healthcare Co Inc
$25.730.04%
Edge Rankings
Momentum
9.47
Growth
95.62
Quality
59.25
Value
76.44
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in